Outcomes of Children After Hospitalization in Intensive Care Unit

NCT ID: NCT06124092

Last Updated: 2023-11-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

690 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-31

Study Completion Date

2029-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

More than 10,000 children are hospitalized in an PICU every year in Canada. While most of them will survive their PICU hospitalization and their critical illness, some children will not recover to their pre-illness level. Some may develop behavioral, physical, emotional or developmental problems and difficulties at school. All these problems are elements that are part of the Pediatric Post-Intensive Care Syndrome (PICS-p).

It is important to understand the elements (risk factors) that play a role in the development of PICS-p. In Canada, there is no systematic follow-up for children after they leave the PICU. Understanding what can cause PICS-p (risk factors) and how much PICS-p has an impact on children and their family is very important to the family well-being.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Pediatric Post-Intensive Care Syndrome (PICS-p) is a newly developed conceptual framework that incorporates the constellation of morbidities that are increasingly recognized to affect children and their families after a critical illness. Experts define PICS-p as a new or worsening impairment in any of the following 5 domains of child health: physical, cognitive, emotional, social, or family.

In contrast to well established follow-up programs in adults, there is currently a lack of systematic follow-up of PICU survivors which prevents both the recognition and management of PICS-p. The absence of granular, empirical data on the recovery of PICU children impedes both the identification and management of PICS-p.

This project is a prospective Canadian multicenter cohort study to identify risk factors of PICS-p, develop and validate a predictive model for PICS-p to detect at-risk children, characterize each domain of PICS-p over two years post critical illness and uncover additional morbidities that are not captured using the current PICS-p framework. This study will provide granular, empirical data on which to build developmentally appropriate and tailored screening, management, and intervention programs during and after PICU to improve the global recovery of critically ill children and their family.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Disease Liver Diseases Heart Diseases Trauma Injury Sepsis Septic Shock Pneumonia Bronchiolitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

neurocognitive tests

Cohort study: all parents and participants will have questionnaires to complete, based on participant's age.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Quality of life

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children ≤18yo hospitalized in PICU for ≥96 hours

Exclusion Criteria

1. gestational age \<37 weeks or age \>18 years at PICU entry;
2. admitted for congenital heart surgery (followed in neuro-cardiac clinics in most centers);
3. anticipated life expectancy \<1year (e.g., active do not resuscitate status).
Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

Sponsor Role collaborator

St. Justine's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Genevieve Du Pont-Thibodeau

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Geneviève Du Pont-Thibodeau, MD

Role: PRINCIPAL_INVESTIGATOR

St. Justine's Hospital

Laurence Cucharme-Crevier, MD

Role: PRINCIPAL_INVESTIGATOR

St. Justine's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alberta Children's Hospital

Calgary, Alberta, Canada

Site Status

BC Children Hospital

Vancouver, British Colombia, Canada

Site Status

McMaster Children's Hospital

Hamilton, Ontario, Canada

Site Status

Childrens Hospital of Eastern Ontario

Ottawa, Ontario, Canada

Site Status

The Hospital for Sick Children

Toronto, Ontario, Canada

Site Status

CHU Sainte-Justine

Montreal, Quebec, Canada

Site Status

Montreal Children Hospital

Montreal, Quebec, Canada

Site Status

Centre Hospitalier Universitaire de Sherbrooke

Sherbrooke, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Geneviève Du Pont-Tibodeau, MD

Role: CONTACT

514-345-4931 ext. 5553

Laurence Ducharme-Crevier, MD

Role: CONTACT

514-345-4931 ext. 4118

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Laurie Lee, MD

Role: primary

Jenny Retallack, MD

Role: primary

Karen Choong, MD

Role: primary

Dayre McNally, MD

Role: primary

Nicole McKinnon

Role: primary

Nadia Roumeliotis, MD

Role: primary

514-345-4931 ext. 7177

Patricia Fontela, MD

Role: primary

Jean-Sébastien Tremblay-Roy, MD

Role: primary

819-346-1100 ext. 70188

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHUSJ MP-21-2023-5097

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

In Home Hospital Care Program
NCT00234780 COMPLETED NA